| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 28 buys and 2 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | Lim Seah H. | Director | Buy | 20,000 | $0.04 | $800.00 | +0.4% | |
| Feb 29, 2024 | Lee Willis C | Co-president &COO | Buy | 115,200 | $0.13 | $14,694.00 | +45.8% | |
| Dec 20, 2023 | Lim Seah H. | Director | Sell | 32,500 | $0.05 | $1,625.00 | -0.7% | |
| Dec 15, 2023 | Lim Seah H. | Director | Sell | 6,000 | $0.11 | $660.00 | -3.4% | |
| Nov 30, 2023 | Lee Willis C | COO | Buy | 15,609 | $0.13 | $2,022.93 | +1.4% | |
| Sep 5, 2023 | Lim Seah H. | Director | Buy | 113,800 | $0.25 | $28,122.00 | +28.7% | |
| May 31, 2023 | Lee Willis C | COO | Buy | 28,700 | $0.29 | $8,323.00 | +1,511% | |
| Nov 30, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 52,600 | $0.40 | $21,225.00 | - | |
| Nov 2, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 27,500 | $0.44 | $11,975.00 | - | |
| Oct 28, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 69,400 | $0.28 | $19,288.00 | +0.1% |